- Report
- August 2026
- 110 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 150 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- July 2026
- 112 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- July 2026
- 135 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- July 2026
- 180 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- April 2026
- 180 Pages
Global
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 181 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- January 2026
- 140 Pages
Global
From €3589EUR$3,950USD£3,085GBP
- Report
- August 2026
- 160 Pages
Global
From €3017EUR$3,320USD£2,593GBP
€3771EUR$4,150USD£3,241GBP
- Report
- July 2026
- 160 Pages
Global
From €3017EUR$3,320USD£2,593GBP
€3771EUR$4,150USD£3,241GBP
- Report
- July 2026
- 160 Pages
Global
From €3017EUR$3,320USD£2,593GBP
€3771EUR$4,150USD£3,241GBP
- Report
- April 2026
- 160 Pages
Global
From €3017EUR$3,320USD£2,593GBP
€3771EUR$4,150USD£3,241GBP
- Report
- January 2026
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- January 2026
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- November 2025
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- October 2025
- 160 Pages
Global
From €2871EUR$3,160USD£2,468GBP
€3589EUR$3,950USD£3,085GBP
- Report
- January 2026
- 211 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- July 2026
- 243 Pages
North America
From €1363EUR$1,500USD£1,171GBP
- Report
- July 2026
- 332 Pages
Europe
From €1363EUR$1,500USD£1,171GBP
- Report
- October 2025
- 89 Pages
Middle East
From €4089EUR$4,500USD£3,514GBP

The genotyping market is a subset of the genomics industry that focuses on the identification of genetic variations between individuals. It is used to identify genetic markers associated with diseases, to determine the risk of developing certain conditions, and to identify the most effective treatments for a given individual. Genotyping is also used in the development of personalized medicine, which is tailored to the individual’s genetic makeup. Genotyping technologies include next-generation sequencing, microarrays, and PCR-based methods.
The genotyping market is expected to grow due to the increasing demand for personalized medicine, the development of new technologies, and the increasing availability of genomic data. Additionally, the increasing prevalence of chronic diseases and the need for more accurate diagnosis and treatment are expected to drive the growth of the genotyping market.
Some companies in the genotyping market include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and PerkinElmer. Show Less Read more